Description

Seven companies listing additional securities on BSE effective November 11, 2025, under their Employee Stock Option Plans.

Summary

BSE has announced the listing and admission for trading of further securities issued by seven companies under their Employee Stock Option Plans (ESOP/ESOS), effective from Tuesday, November 11, 2025. The circular details share quantities, ISIN codes, face values, and lock-in periods where applicable.

Key Points

  • Total of seven companies listing additional equity shares under ESOP/ESOS schemes
  • Effective date for trading: November 11, 2025
  • Combined total of approximately 902,324 new shares being listed
  • Three companies have lock-in periods: Bliss GVS Pharma (until April 10, 2026), while others have no lock-in
  • All securities are equity shares with varying face values

Companies and Share Details

  1. Arvind Fashions Limited (INE955V01021, Scrip: 542484)

    • Shares: 22,279
    • Face Value: ₹4
    • Lock-in: None

  2. Bliss GVS Pharma Limited (INE416D01022, Scrip: 506197)

    • Shares: 39,450
    • Face Value: ₹1
    • Lock-in: Until April 10, 2026

  3. Carborundum Universal Ltd (INE120A01034, Scrip: 513375)

    • Shares: 3,000
    • Face Value: ₹1
    • Lock-in: None

  4. Edelweiss Financial Services Ltd (INE532F01054, Scrip: 532922)

    • Shares: 367,683
    • Face Value: ₹1
    • Lock-in: None

  5. IIFL Capital Services Limited (INE489L01022, Scrip: 542773)

    • Shares: 252,550
    • Face Value: ₹2
    • Lock-in: None

  6. Mphasis Limited (INE356A01018, Scrip: 526299)

    • Shares: 155,762
    • Face Value: ₹10
    • Lock-in: None

  7. UNO Minda Limited (INE405E01023, Scrip: 532539)

    • Shares: 61,600
    • Face Value: ₹2
    • Lock-in: None

Regulatory Changes

No regulatory changes introduced. This is a routine listing notification for securities issued under existing ESOP/ESOS frameworks.

Compliance Requirements

  • Trading members are informed to note the new securities for trading purposes
  • Lock-in restrictions must be observed for Bliss GVS Pharma shares until April 10, 2026
  • All other securities are freely tradable from the listing date

Important Dates

  • Notice Date: November 10, 2025
  • Effective Trading Date: November 11, 2025
  • Lock-in Expiry (Bliss GVS Pharma only): April 10, 2026

Impact Assessment

Minimal market impact expected as ESOP issuances represent routine corporate actions with limited dilution. The largest issuance is Edelweiss Financial Services with 367,683 shares. Only one company (Bliss GVS Pharma) has a lock-in period, indicating most shares are immediately available for trading. This is standard operational activity for listed companies managing employee compensation plans.

Impact Justification

Routine ESOP listing with minimal market impact; affects limited number of shares across seven companies